Other · VGF-derived neuroendocrine peptide
Neuroendocrine regulatory peptide-1 (NERP-1)
Also known as NERP-1
A 26-residue VGF-derived peptide studied for its role in hypothalamic signalling and experimental regulation of vasopressin secretion.
- Length
- 26 amino acids
- Half-life
- Not well characterised
- Mechanism
- NERP-1 modulates hypothalamic circuits controlling vasopressin secretion, with inhibitory effects reported in rodent experimental systems. Its direct receptor has not been conclusively identified, so effects on neuronal signalling should not be attributed to a defined receptor target.
- Studied in
- Rodent hypothalamic explants, neurosecretory preparations and animal models of osmotic challenge are used to investigate NERP-1-dependent regulation of vasopressin release.
About Neuroendocrine regulatory peptide-1 (NERP-1)
NERP-1 is a 26-amino-acid peptide generated by proteolytic processing of VGF, a secretory precursor expressed in neuronal and endocrine cells. Despite its name, VGF is not a member of the vascular endothelial growth factor family. NERP-1 and NERP-2 were reported in 2007 following the identification of endogenous VGF-derived peptides. Their discovery linked processing of this granin-like precursor to neuroendocrine mechanisms involved in water-balance signalling.
Experimental work places NERP-1 within hypothalamic networks associated with vasopressin-producing neurons, including the supraoptic and paraventricular nuclei. Rodent preparations have been used to examine how the peptide alters stimulated vasopressin secretion and local neuronal communication. These observations establish a functional research context rather than a settled ligand–receptor relationship. A validated molecular receptor remains unresolved, and interpretations should distinguish direct peptide actions from effects mediated through neighbouring cells or circuit-level feedback.
Laboratory notes
- Confirm the species-specific sequence and terminal chemistry against the analytical certificate; VGF fragment numbering can differ between species.
- Prepare single-use aliquots using a solvent validated for the supplied material, and minimise repeated freeze–thaw cycles.
- Pair secretion assays with viability measurements and an appropriate scrambled-peptide control; altered vasopressin release alone does not identify a receptor.
Storage and reconstitution basics: storage guide.
Questions about Neuroendocrine regulatory peptide-1 (NERP-1)
Is NERP-1 a vasopressin-receptor ligand?
No established evidence identifies NERP-1 as a direct vasopressin-receptor ligand. Its reported effects concern regulation of vasopressin secretion, while its own receptor remains unresolved.
How does NERP-1 relate to VGF?
NERP-1 is a discrete peptide released through processing of the larger VGF precursor, rather than a separately encoded protein.
Which readouts are useful in NERP-1 experiments?
Common mechanistic readouts include vasopressin in explant supernatants, neuronal activity and responses to controlled osmotic stimulation. Orthogonal measurements help distinguish secretion changes from tissue damage.
Is Neuroendocrine regulatory peptide-1 (NERP-1) for human use?
No. It is supplied strictly for in-vitro laboratory research and is not for human or animal consumption.
Related research peptides
All products are sold for laboratory research use only. Not for human consumption, not a medicine, not for diagnosing, treating or preventing any condition.